Tirzepatide Weight Loss NJ: How It Transforms Your Journey
Harnessing Dual Incretin Agonism: The Scientific Foundation of Tirzepatide in Weight Loss In the evolving landscape of obesity medicine, tirzepatide represents a paradigm shift by leveraging dual incretin agonism targeting both GLP-1 and GIP receptors. This novel mechanism amplifies metabolic modulation beyond traditional mono-agonists, enhancing insulin sensitivity, appetite regulation, and energy expenditure. For patients in … Read more